Search

everythinglearnresearchcommunity

for

Search:↓

The nutritional supplement Pilopeptan® WOMAN improved hair growth and thickness in women with hair loss.

Low-dose isotretinoin is effective for treating pediatric scarring alopecia.

JAK inhibitors like baricitinib and ritlecitinib are effective new treatments for severe alopecia areata.

Sansevieria trifasciata shows promise as a natural treatment for hair loss.

Trichostasis spinulosa can look like acne but usually affects adults, not children.

Combining excimer lamp and tofacitinib gel may help treat hair loss in children.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Phenylephrine may help prevent hair loss from pulling on the hair roots.

Microemulsions improve adapalene's skin absorption for better acne treatment.

Baricitinib helps treat severe hair loss in people over 65.

A patient experienced long-lasting hair loss after using acitretin for psoriasis.

Alopecia areata causes significant emotional distress, including high rates of depression and anxiety.

PRP is a promising alternative for alopecia areata due to its safety and patient satisfaction.

Intralesional triamcinolone is the most effective treatment for hair regrowth in alopecia areata patients.

Oral isotretinoin temporarily improved skin symptoms in a child with IFAP syndrome.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

A new tool can predict hair regrowth in patchy alopecia areata patients.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Using isotretinoin gel and minoxidil solution together effectively regrows hair in most people with patchy hair loss.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

Isotretinoin effectively treats severe acne but has significant side effects requiring careful monitoring.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Baricitinib may help people with long-term alopecia areata.

Activating Tgr5 may help treat hair loss and bone loss.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Fat-derived stem cells show promise for skin repair and reducing aging signs but need more research for consistent results.

Statins do not help improve alopecia areata.

Insurance coverage for scalp cooling will make it more accessible to all chemotherapy patients.